#148 - Meet The Ibogaine Psychedelic Scientist Who First Unravelled Its Big Mystery

0:00-1:02:18

🧠 JOIN THE GIANT’S SHOULDER FAMILY Become a YouTube Member for exclusive episodes, early access + ad-free viewing: https://www.youtube.com/@thegiantsshoulder/join Deborah Mash is a neuropharmacologist who holds the first FDA licence ever granted to give ibogaine to a human being, built one of America's largest brain banks, and discovered noribogaine — the metabolite now entering its first US clinical trial. She has spent over thirty years on a drug that appears to interrupt addiction after a single dose. This April a US president named it specifically. This is the scientist who was right three decades early. Expect to learn what Trump's executive order actually changes for ibogaine, why Sasha Shulgin put ibogaine in a box of its own, how noribogaine blocks nicotine, alcohol, cocaine and opioid use in animal models, why ibogaine holds the brain's neuroplasticity window open for four weeks when ketamine manages days, why some patients get the full therapeutic benefit with no psychedelic experience at all, why the reported ibogaine deaths are almost impossible to interpret, why more than 80% of her patients said they never wanted to repeat it, and much more...

Publisher

Giants Shoulder

Link

podcasters.spotify.com/pod/show/evanmcgloughlin/episodes/148---Meet-The-Ibogaine-Psychedelic-Scientist-Who-First-Unravelled-Its-Big-Mystery-e3njlfe

Published

August 20, 2026

Duration

1h 2m

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Evan McGloughlin

GS

Giants Shoulder

@giantsshoulder

#ibogainepsychedelicscientist #unravelled #bigmystery #lifesciences

The Nile